NCT05442216 · Interventional trial
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Overall registry status Recruiting
Phase 2
Conditions Acute Myeloid Leukemia
Delaware Valley sites
- Penn Medicine Abramson Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory